These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 947712)

  • 1. Treatment of chronic urinary tract infections with cephalexin (Ceporexine) orally administered at 12-hourly intervals.
    Nilsson LB
    Chemotherapy; 1976; 22(5):331-4. PubMed ID: 947712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of long-term treatment of urinary tract infection with a single dose in the evening.
    Sourander L; Saarimaa H
    Chemotherapy; 1975; 21(1):52-5. PubMed ID: 1149563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical comparison of cefadroxil, new oral cephalosporin, and cephalexin in uncomplicated urinary tract infection.
    Bolding OT
    Urology; 1978 Sep; 12(3):321-4. PubMed ID: 360561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative double-blind study of cephalexin and co-trimoxazole in urinary tract infections.
    Gower PE; Tasker PR
    Br Med J; 1976 Mar; 1(6011):684-6. PubMed ID: 1252882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute uncomplicated urinary tract infections by cephalexin, with special reference to the antibody-coated bacteria.
    Iravani A; Pryor N; Richard GA
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):97-100. PubMed ID: 7068290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, comparative, open study of cefadroxil administered once or twice daily in urinary tract infections.
    Rugendorff EW
    J Antimicrob Chemother; 1982 Sep; 10 Suppl B():57-63. PubMed ID: 7142095
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative studies of the efficacy, safety and usefulness of S6472, cefaclor and cephalexin on complicated urinary tract infection by the double-blind method].
    Kamidono S; Arakawa S; Fujii A; Kataoka N; Umezu K; Ishigami J; Hirooka K; Shimatani N; Matsushita M; Hikosaka K
    Jpn J Antibiot; 1985 Oct; 38(10):2735-69. PubMed ID: 3908727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sustained release cephalexin (S-6436) and genitourinary tract infection (author's transl)].
    Furusawa T; Tanaka S
    Jpn J Antibiot; 1977 Oct; 30(10):806-18. PubMed ID: 592483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical experience with S-6436 in urinary tract infections (author's transl)].
    Yamamoto H; Oida S; Ohtsuki A; Hosomi T; Kubo Y
    Jpn J Antibiot; 1977 Oct; 30(10):825-8. PubMed ID: 592485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of pivmecillinam and cephalexin in acute uncomplicated urinary tract infection.
    Menday AP
    Int J Antimicrob Agents; 2000 Jan; 13(3):183-7. PubMed ID: 10724022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of urinary tract infection with cephalexin.
    Kostas CI; Mobley DF; Rous SN; Schneider RE; Burt RA
    J Fam Pract; 1983 Jul; 17(1):135, 138-40. PubMed ID: 6864165
    [No Abstract]   [Full Text] [Related]  

  • 12. Cephalexin in the therapy of infections of the urinary tract.
    Weinstein AJ
    Postgrad Med J; 1983; 59 Suppl 5():40-2. PubMed ID: 6664942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cephalexin in urinary tract infections.
    Seneca H; Uson A; Peer P
    J Urol; 1972 May; 107(5):832-4. PubMed ID: 5022555
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experience with sustained release cephalexin (S-6436) in urology (author's transl)].
    Konya H; Kuroda J; Iwao N
    Jpn J Antibiot; 1977 Nov; 30(11):898-905. PubMed ID: 592491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic long-term cephalexin in recurrent urinary infection.
    Fairley KF; Hubbard M; Whitworth JA
    Med J Aust; 1974 Mar; 1(9):318-9. PubMed ID: 4824002
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of small doses of cephalexin (125 mg) in the management of recurrent urinary tract infection in women.
    Gower PE
    J Antimicrob Chemother; 1975; 1(3 Suppl):93-8. PubMed ID: 1104559
    [No Abstract]   [Full Text] [Related]  

  • 17. Double-blind comparison of carbenicillin indanyl sodium, ampicillin, and cephalexin in treatment of urinary tract infection.
    Ries KM; Cobbs CG; Gillenwater JY; Levison ME; Mandell GL; Sande MA; Kaye D
    Antimicrob Agents Chemother; 1973 Dec; 4(6):593-6. PubMed ID: 4602827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective prophylaxis of recurrent urinary tract infections in premenopausal women by postcoital administration of cephalexin.
    Pfau A; Sacks TG
    J Urol; 1989 Nov; 142(5):1276-8. PubMed ID: 2810506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of prophylactic, low dose cephalexin on fecal and vaginal bacteria.
    Martinez FC; Kindrachuk RW; Thomas E; Stamey TA
    J Urol; 1985 Jun; 133(6):994-6. PubMed ID: 3999226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cephalexin compared with ampicillin in urinary tract infections in children.
    Elo J; Ahava K
    J Antimicrob Chemother; 1975; 1(3 Suppl):85-92. PubMed ID: 1104558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.